Articles tagged with Chemotherapy
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
Researchers have discovered that a natural compound from magnolia cones can block a previously 'undruggable' pathway for cancer growth. This finding could lead to the development of new treatments by making tumors more sensitive to traditional chemotherapy drugs.
A new study from Duke University Medical Center found that changes in doctors' reimbursement for chemotherapy treatments did not affect patients' access to care. The study measured patient access by looking at distance traveled and time between diagnosis and initiation of chemotherapy.
New research indicates that the Medicare Modernization Act of 2003 has not led to significant changes in patient wait times or travel distance for chemotherapy treatment. The study found that the number of patients traveling farther for chemotherapy remained stable after 2003, with no major increases in wait times.
Researchers at UC San Diego develop a nanoscale drug delivery system targeting integrin ανβ3 protein on tumor blood vessels, reducing collateral damage. The approach shows promise in treating metastatic disease with lower chemotherapy doses.
Researchers at ESMO Conference Lugano report improved treatment outcomes for aggressive non-Hodgkin's lymphoma patients when chemotherapy is administered every 2 weeks, rather than every 3 weeks.
Researchers at McGill University have discovered a compound called silvestrol that can re-sensitize tumors to chemotherapy, making them susceptible to anticancer drugs. Silvestrol, derived from Malaysian folk medicine, has been shown to effectively reduce resistance to chemotherapy agents used to treat cancer.
A study showed that Caphosol use led to lower OM rates and severity, as well as low pain medication use and high patient satisfaction among cancer patients. High efficacy ratings were also reported by physicians.
Researchers at Ohio State University found that acute myeloid leukemia (AML) patients with mutations in the RAS gene are more likely to be cured when treated with high doses of cytarabine. Testing for RAS mutations may help doctors identify which AML patients should receive this therapy.
The study introduces HB-19, an experimental synthetic molecule that inhibits both tumor cell growth and angiogenesis. In mice models, HB-19 treatment suppresses tumor development and eliminates measurable tumors without toxicity.
A new study found that women with severe SLE who received a 6-month course of cyclophosphamide followed by mycophenolate mofetil treatment had preserved ovarian function and fertility. Disease activity was equally controlled in both groups, but patients treated with long-course CYC pulses had a higher risk of amenorrhea.
A new class of compounds, cyclopenta[b]benzofuran flavaglines, has been found to inhibit translation initiation and reverse cancer cell resistance to anticancer agents. This approach targets the eIF4A protein, which plays a central role in translation initiation.
Dan Savage, 25, survived testicular cancer at 20, gaining more confidence and starting his own art studio. He worries about losing regular medical checks after five years in remission, feeling the need for continued health monitoring.
Researchers found that solid tumor cells can adapt to chemotherapy and radiation by increasing a regulatory factor called HIF1, which drives oxygen production and growth. Blocking HIF1 may provide a clear mechanism for killing resistant tumor cells.
A pilot study at Duke University Medical Center found that disabling a protein on melanoma cells makes them more vulnerable to chemotherapy, resulting in complete responses in 8 out of 16 patients. The compound ADH-1 was tested in combination with chemotherapy and showed promising results.
Physician-scientists from NewYork-Presbyterian/Weill Cornell presented Phase II trial data showing a monoclonal antibody targeting prostate cancer cells effectively reduces PSA levels in patients with late-stage metastatic disease. The researchers also present results on RAD001, which slows cancer progression in recurrent endometrial c...
A study by Dana-Farber Cancer Institute found that chemotherapy can diminish ovarian reserve, making it harder for premenopausal breast cancer survivors to get pregnant. The research suggests that tracking breast cancer survivors' fertility after treatment is crucial.
USC researchers have identified specific genetic markers in cancer cells that predict the benefit of a novel cancer drug. The study suggests that patients with tumors exhibiting these gene expression profiles may experience increased patient benefit from the incorporation of the drug into their treatment.
Researchers reviewing randomized trials found that antioxidant supplementation may reduce overall survival in patients receiving radiotherapy. Conversely, no clear evidence suggests that antioxidant treatment increases tumor response rates during chemotherapy.
CAPHOSOL, an advanced electrolyte solution, has been shown to relieve oral mucositis and improve quality of life for cancer patients. The study found that 95% of patients reported favorable OM scores and high levels of patient and practitioner satisfaction with CAPHOSOL.
A quality-control audit found high compliance with Fox Chase Cancer Center's Partners program, which shares advanced cancer treatment guidelines with community hospitals. The study suggests that this partnership is an effective model for quickly disseminating advances in cancer treatment.
A study presented at the American Society of Clinical Oncology annual meeting found that adding epratuzumab to standard chemotherapy (R-CHOP) resulted in a 95% response rate and 63% disease-free survival in patients with diffuse large B-cell lymphoma. The treatment was well-tolerated, but final results will be reported next year.
Researchers conclude that adding chemotherapy to active symptom control does not improve overall survival or quality of life for mesothelioma patients. However, exploratory analyses suggest that vinorelbine may merit further investigation.
A new study suggests that targeting and disabling a protein in melanoma tumors can make them more vulnerable to chemotherapy. Researchers found that combining targeted therapy with melphalan chemotherapy reduced tumor size by up to 30-fold, compared to chemotherapy alone.
A study by Mayo Clinic researchers found that administering calcium and magnesium before and after oxaliplatin chemotherapy significantly reduces neurological side effects in patients with advanced colon cancer. This reduction enables patients to complete a full course of treatment, increasing the likelihood of successful therapy.
A new study from the University of Michigan Comprehensive Cancer Center found that black patients are 23% less likely to receive chemotherapy and 12% less likely to receive radiation therapy for rectal cancer compared to white patients. Despite similar rates of consultation with oncologists, disparities in treatment initiation persist.
Researchers assessed various regimens for treating advanced gastric cancer and found that new agent-containing regimens can achieve higher response rates. Chemotherapy with 5-fluorouracil remains a mainstream treatment option, prolonging median survival time for AGC patients.
A study by researchers at Baylor College of Medicine found that conventional chemotherapy often fails to eliminate breast cancer stem cells, leading to potential relapse. Treatment with lapatinib and other drugs appears to kill both tumor cells and stem cells, reducing the risk of recurrence in patients with HER2-positive tumors.
A new clinical trial found that MAGE-A3 ASCI reduces the risk of lung cancer relapse after surgery, similar to chemotherapy but with fewer side effects. The treatment, which boosts the immune system, showed minimal reactions at injection sites and was suitable for long-term maintenance treatment.
A clinical trial evaluating sorafenib added to carboplatin/paclitaxel chemotherapy for lung cancer patients showed the combination offers no improved overall survival. Sorafenib results in worse outcomes for some patients with squamous histology.
A new treatment combination using a genetically altered herpes virus and chemotherapy drug reduces tumor size in mice with aggressive human sarcoma. The therapy appears to be well-tolerated, but further development is needed before clinical trials can begin.
A randomized controlled trial found that chemotherapy with cisplatin before concurrent chemoradiation did not improve disease-free survival for patients with anal canal cancer. The therapy resulted in a higher rate of colostomy procedures and was associated with severe hematologic toxicity.
Researchers detail chemotherapy's damage to the brain, finding that healthy cells die off long after treatment ends. The study identifies 5-fluorouracil as a contributor to chemo brain, with damaged oligodendrocytes leading to cognitive decline and demyelination.
Researchers found that a single chemotherapeutic agent, 5-fluorouracil, can cause delayed degeneration in the central nervous system of mice, leading to extensive myelin pathology. This damage is not self-repairing and worsens over time.
The 'GeparQuattro' trial shows that combining anthracycline and taxane chemotherapy with trastuzumab improves HER2 breast cancer response rates to 41.3%, compared to 19.5% without trastuzumab. The regimen also minimizes cardiac toxicity, making it a promising treatment option.
A recent study found that women with BRCA2-associated breast cancer had a higher response rate and longer overall survival when treated with anthracycline-based regimens. Researchers believe this may be due to the lack of functional BRCA1/2 proteins, which impair DNA repair after chemotherapy.
A new chemotherapy combination of docetaxel and capecitabine showed no improved efficacy in early breast cancer treatment, but increased non-haematological toxicities. The study found that the addition of capecitabine produced more side effects, such as hand-foot syndrome and diarrhoea.
Two studies suggest that chemotherapy is not the cause of memory problems in breast cancer patients, but rather stress and quality of life factors. Women with recent diagnoses performed similarly on cognitive tests to those without cancer, while those who had completed treatment showed better scores.
Researchers at UAB have discovered that triphendiol induces cell death in pancreatic and bile duct cancer cells, slowing tumor growth and sensitizing tumors to chemotherapy treatments. The investigational drug has shown promise as a potential treatment for pancreatic adenocarcinoma.
The Novo-TTF device demonstrated significant efficacy in reducing tumor volume and improving outcomes for patients with locally advanced breast cancer. The device's non-invasive technology disrupts cancer cell proliferation, offering a potential alternative to traditional chemotherapy.
Recent studies suggest that preoperative chemotherapy can be effective in early breast cancer treatment, but individual responses may vary. Additionally, a case-control study found no increased risk of cancer among frequent blood donors. Furthermore, researchers have identified a novel mechanism to overcome resistance to targeted thera...
A randomized controlled trial found that high-dose chemotherapy did not increase survival rates for patients with small cell lung cancer. Despite increased tumor shrinkage, the high-intensity approach was deemed ineffective and highly toxic.
Researchers used nanotechnology to target tumors in rabbits, achieving a 1,000-fold reduction in chemotherapy dose while slowing tumor growth. The nanoparticles delivered a fungal toxin called fumagillin directly to growing blood vessels, inhibiting tumor expansion.
A study integrating genetic information with breast cancer risk factors refines estimates of relapse-free survival and predicts response to chemotherapy. Gene expression signatures provide valuable insights into breast cancer heterogeneity, enabling more precise clinical outcomes.
Researchers at USC have found that fasting for two days protects healthy cells from chemotherapy, while leaving cancer cells vulnerable. This discovery holds promise for developing more selective and less toxic chemotherapy treatments.
Researchers have created a novel nanomachine, called nanoimpeller, that can capture and store anticancer drugs inside tiny pores and release them into cancer cells in response to light. The device has strong implications for cancer treatment and may open a new avenue for drug delivery under external control.
The EORTC Intergroup trial found that chemotherapy plus surgery on liver tumors improved progression-free survival by 26% in patients with colorectal cancer. Patients who received chemotherapy before and after surgery had a higher rate of progression-free survival compared to those who underwent surgery alone.
Researchers at IUPUI have created the first 3-D image of how bleomycin targets and binds to DNA. This breakthrough study may lead to improved chemotherapy drugs for various cancers.
A study of 61 patients with follicular non-Hodgkin lymphoma found that radioimmunotherapy with yttrium-90 ibritumombab tiuxetan was well-tolerated and effective, achieving complete response in 55 patients. The treatment also showed improved progression-free survival and overall survival rates.
AstraZeneca's investigational cancer drug vandetanib has completed patient enrollment in two pivotal Phase III studies for the second-line treatment of non-small cell lung cancer. The ZODIAC and ZEAL studies aim to assess the efficacy of vandetanib in combination with chemotherapy treatments.
A randomized clinical trial found that postoperative chemotherapy does not improve survival in patients with localized gastric cancer. Despite promising results in advanced gastric cancer, the combination of cisplatin, epirubicin, and other chemotherapies did not show significant benefits.
A new study has demonstrated a lower risk of cardiac toxicity with dose-dense chemotherapy in early-stage HER2-positive breast cancer patients. The regimen, which administers standard doses of chemotherapy agents more frequently, pairs safely with trastuzumab and resulted in only 1.4% cardiac events after 28 months of follow-up.
A study found that adding gemcitabine to chemoradiation improved survival rates for pancreatic cancer patients who had surgery, but the benefit was not statistically significant. The treatment reduced local relapse and systemic metastasis in patients.
Differences in gene expression levels between people of European and African ancestry can impact how they respond to certain drugs. The study found significant differences in several unrelated processes, including genes involved in producing antibodies to microbial invaders.
Research finds that TS genotype is associated with protein expression levels, which can predict patient response to 5-FU-based chemotherapy. Patients with triple-repeated genotypes have higher intratumoral TS protein expression and better clinical outcomes.
A study found that people with gliomatosis cerebri missing chromosome 1p and 19q respond better to temozolomide and live longer. The genetic signature was associated with a higher response rate and longer survival, making temozolomide a preferred treatment option.
A new study reveals that Avastin's side effects may be caused by the blockage of VEGF, which normally protects brain cells from fluid leakage. In mice, this blockage led to brain swelling and cell death.
A team of researchers has identified a new mechanism that explains why some recurrent ovarian tumors become resistant to treatment with cisplatin and carboplatin. They found that secondary mutations on the BRCA2 gene restore DNA repair function, making cancer cells resistant to chemotherapy.
Researchers identify nerve that transmits signals of chemotherapy-associated illness from small intestine to brain, offering new approach to reduce debilitating side effects. Anorexia and cachexia often accompany chemotherapy symptoms, compromising patient's nutritional status.
Research reveals high-dose methotrexate significantly increases average survival rate to 4.5 years, outperforming radiation therapy with a one-year average survival rate.
A study of 227 breast cancer patients found that those who participated in a psychological intervention program had better health and functioning scores, with a 7% increase compared to non-participants. The program included training on relaxation, coping with stress, and strategies for improving health behaviors, resulting in fewer sym...